Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp

Clinical Microbiology and Infection

Volumn 10, Issue SUPPL. 1, 2004, Pages 76-85

  Bouza, E ^a   Munoz P ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Blastoschizomyces capitatus; Neutropenia; Opportunistic infection invasive mycosis; S. apiospermum; Scedosporium prolificans

Indexed keywords

ALBACONAZOLE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MICONAZOLE; PENTAMIDINE; TERBINAFINE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; BLASTOSCHIZOMYCES CAPITATUS; BLOOD CULTURE; DRUG CHOICE; FEVER; FUNGUS; GEOTRICHUM CAPITATUM; HUMAN; IN VITRO STUDY; MYCOSIS; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SIDE EFFECT;

DIPODASCUS; DIPODASCUS CAPITATUS; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS;

EID: 1642319728     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1470-9465.2004.00842.x     Document Type: Article

References (131)

1. Salkin I, Gordon M, Samsonoff W, Rieder C. Blastoschizomyces capitatus, a new combination. Mycotaxon 1985; 22: 375-80.
2. D'Antonio D, Mazzoni A, Iacone A et al. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J Clin Microbiol 1996; 34: 753-5.
3. Polacheck I, Salkin IF, Kitzes-Cohen R, Raz R. Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J Clin Microbiol 1992; 30: 2318-22.
4. Gueho E, de Hoog GS, Smith MT, Meyer SA. DNA relatedness, taxonomy, and medical significance of Geotrichum capitatum. J Clin Microbiol 1987; 25: 1191-4.
5. Gemeinhardt H. [On the problem of pathogenicity of the yeast fungus Trichosporon capitatum in the respiratory tract of man. A contribution to the diagnosis of pulmonary mycoses]. Z Tuberk Erkr Thoraxorg 1965; 124: 190-7.
6. Gemeinhardt H. Lungenpathogenitat von Trichosporon capitatum beim menschen. Zentralbl Bakteriol [Orig] 1965; 196: 121-33.
7. Gemeinhardt H. [On the occurrence of Trichosporon capitatum (Diddens et Lodder 1942) in human specimen]. Zentralbl Bakteriol [Orig] 1967; 202: 109-16.
8. Martino P, Venditti M, Micozzi A et al. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis 1990; 12; 570-82.
9. Randhawa HS, Mussa AY, Khan ZU. Decaying wood in tree trunk hollows as a natural substrate for Cryptococcus neoformans and other yeast-like fungi of clinical interest. Mycopathologia 2001; 151: 63-9.
10. Mathews MS, Sen S. Blastoschizomyces capitatus infection after contamination of fluids for intravenous application. Mycoses 1998; 41: 427-8.
11. Aalbaek B, Stenderup J, Jensen HE, Valbak J, Nylin B, Huda A. Mycotic and algal bovine mastitis in Denmark. Apmis 1994; 102: 451-6.
12. Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis 1983; 147: 199-203.
13. D'Antonio D, Romano F, Iacone A et al. Onychomycosis caused by Blastoschizomyces capitatus. J Clin Microbiol 1999; 37: 2927-30.
14. Grunder K. [Trichosporon capitatum as pathogen of dermatomycoses]. Hautarzt 1976; 27: 422-5.
15. Restrepo A, De Uribe L. Isolation of fungi belonging to the genera Geotrichum and Trichosporum from human dermal lesions. Mycopathologia 1976; 59: 3-9.
16. Gilbert W, Fetter B. Experimental infection in the rabbit with Trichosporon capitatum. J Bacteriol 1962; 84: 961-6.
17. Pospisil J, Postupa J, Otcenasek M, Vejbora O. Pathogenicity of Trichosporon capitatum for normal and irradiated mice and the efficacy of miconazole on experimental systemic trichosporosis in mice. Mycoses 1990; 33: 559-66.
18. Pérez-Sánchez I, Anguita J, Martín-Rabadán P et al. Blastoschizomyces capitatus infection in acute leukemia patients. Leukemia Lymphoma 2000; 391: 209-12.
19. Martino P, Girmenia C, Venditti M et al. Spontaneous pneumothorax complicating pulmonary mycetoma in patients with acute leukemia. Rev Infect Dis 1990; 12: 611-17.
20. Ito T, Ishikawa Y, Fujii R et al. Disseminated Trichosporon capitatum infection in a patient with acute leukemia. Cancer 1988; 61: 585-8.
21. Liu KL, Herbrecht R, Bergerat JP, Koenig H, Waller J, Oberling F. Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation. Bone Marrow Transplant 1990;6: 219-21.
22. Sanz MA, Lopez F, Martinez ML et al. Disseminated Blastoschizomyces capitatus infection in acute myeloblastic leukaemia. Report of three cases. Support Care Cancer 1996; 4: 291-3.
23. Arnold AG, Gribbin B, De Leval M, Macartney F, Slack M. Trichosporon capitatum causing recurrent fungal endocarditis. Thorax, 1981; 36: 478-80.
24. Winston DJ, Balsley GE, Rhodes J, Linne SR. Disseminated Trichosporon capitatum infection in an immunosuppressed host. Arch Intern Med 1977; 137: 1192-5.
25. Cheung MY, Chiu NC, Chen SH, Liu HC, Ou CT, Liang DC. Mandibular osteomyelitis caused by Blastoschizomyces capitatus in a child with acute myelogenous leukemia. J Formos Med Assoc 1999; 98: 787-9.
26. Ortiz AM, Sanz-Rodriguez C, Culebras J et al. Multiple spondylodiscitis caused by Blastoschizomyces capitatus in an allogeneic bone marrow transplantation recipient. J Rheumatol 1998; 25: 2276-8.
27. Barbor PR, Rotimi VO, Fatani H. Paravertebral abscess caused by Trichosporon capitatum in a child with acute lymphoblastic leukaemia. J Infect 1995; 31: 251-2.
28. D'Antonio D, Piccolomini R, Fioritoni G et al. Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol 1994; 32: 224-7.
29. Krcmery S, Dubrava M, Krcmery V Jr. Fungal urinary tract infections in patients at risk. Int J Antimicrob Agents 1999; 11: 289-91.
30. Krcmery V, Laho L, Huttova M et al. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia. J Med Microbiol 2002; 51: 110-16.
31. Buchta V, Zak P, Kohout A, Otcenasek M. Case report. Disseminated infection of Blastoschizomyces capitatus in a patient with acute myelocytic leukaemia. Mycoses 2001; 44: 505-12.
32. Paz I, Barbeyto L, Tinajas A, Sastre JL, Rodriguez-Tudela JL. [Blastoschizomyces capitatus fungemia in a neutropenic patient]. Enferm Infecc Microbiol Clin 2000; 18: 291-2.
33. DeMaio J, Colman L. The use of adjuvant interferon-gamma therapy for hepatosplenic Blastoschizomyces capitatus infection in a patient with leukemia. Clin Infect Dis 2000; 31: 822-4.
34. Oelz O, Schaffner A, Frick P, Schaer G. Trichosporon capitatum: thrush-like oral infection, local invasion, fungaemia and metastatic abscess formation in a leukaemic patient. J Infect 1983; 6: 183-5.
35. Krcmery V Jr, Mateicka F, Kunova A et al. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazole. Support Care Cancer 1999; 7: 39-43.
36. Schiemann R, Glasmacher A, Bailly E et al. Geotrichum capitatum septicaemia in neutropenic patients: case report and review of the literature. Mycoses 1998; 41: 113-16.
37. Fouassier M, Joly D, Cambon M, Peigue-Lafeuille H, Condat P. [Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature]. Rev Med Interne 1998; 19: 431-3.
38. Pagano L, Morace G, Ortu-La Barbera E, Sanguinetti M, Leone G. Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia. Ann Hematol 1996; 73: 33-4.
39. Amft N, Miadonna A, Viviani MA, Tedeschi A. Disseminated Geotrichum capitatum infection with predominant liver involvement in a patient with non Hodgkin's lymphoma. Haematologica 1996; 81: 352-5.
40. Plum G, Scheid C, Franzen C, Schutt-Gerowitt H, Seifert H, Wickramanayake PD. Empirical liposomal amphotericin-B therapy in a neutropenic patient: breakthrough of disseminated Blastoschizomyces capitatus infection. Zentralbl Bakteriol 1996; 284: 361-6.
41. Cofrancesco E, Viviani MA, Boschetti C, Tortorano AM, Balzani A, Castagnone D. Treatment of chronic disseminated Geotrichum capitatum infection with high cumulative dose of colloidal amphotericin B and itraconazole in a leukaemia patient. Mycoses 1995; 38: 377-84.
42. Sycova-Mila Z, Sufliarsky J, Trupl J, Jasenska Z, Blahva M, Krcmery V Jr. Catheter-associated septicaemia due to Trichosporon capitatum. J Hosp Infect 1992; 22: 257-8.
43. Herbrecht R, Liu KL, Koenig H et al. [Trichosporon capitatum septicemia. Apropos Cases]. Agressologie 1992; 2: 96-8.
44. Anaissie E, Gokaslan A, Hachem R et al. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992; 15: 781-7.
45. Girmenia C, Micozzi A, Venditti M et al. Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis 1991; 10: 752-6.
46. Herbrecht R, Liu KL, Koenig H et al. [Trichosporon capitatum septicemia in immunosuppressed patients]. Pathol Biol (Paris) 1990; 38: 585-8.
47. Mahul P, Piens MA, Guyotat D et al. Disseminated Geotrichum capitatum infection in a patient with acute myeloid leukemia. Mycoses 1989; 32: 573-7.
48. Moreno S, Buzon L, Sanchez-Sousa A. Trichosporon capitatum fungemia and intravenous drug abuse. Rev Infect Dis 1987; 9: 1202-3.
49. Baird DR, Harris M, Menon R, Stoddart RW. Systemic infection with Trichosporon capitatum in two patients with acute leukaemia. Eur J Clin Microbiol 1985; 4: 62-4.
50. Groll AH, Walsh TJ. Uncommon opportunistic-fungi: new nosocomial threats. Clin Microbiol Infect 2001; 7(suppl. 2): 8-24.
51. Venditti M, Posteraro B, Morace G, Martino P. In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus. J Chemother 1991; 3: 13-15.
52. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998; 36: 198-202.
53. Herreros E, Almela MJ, Lozano S, Gomez de las Heras F, Gargallo-Viola D. Antifungal activities and cytotoxicity studies of six new azasordarins. Antimicrob Agents Chemother 2001; 45: 3132-9.
54. Herreros E, Martinez CM, Almela MJ, Marriott MS, De Las Heras FG, Gargallo-Viola D. Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi. Antimicrob Agents Chemother 1998; 42: 2863-9.
55. Matthews RC, Burnie JP, Fox A, Woods M, Tabaqchali S. Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections. J Clin Microbiol 1986; 23: 395-7.
56. Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002; 34: 467-76.
57. Lennon PA, Cooper CR Jr, Salkin IF, Lee SB. Ribosomal DNA internal transcribed spacer analysis supports synonomy of Scedosporium inflatum and Lomentospora prolificans. J Clin Microbiol 1994; 32: 2413-16.
58. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954-8.
59. Carrillo AJ, Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001; 45: 2151-3.
60. Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999; 43: 149-51.
61. Berenguer J, Rodriguez-Tudela JL, Richard C et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore) 1997; 76 (4): 256-65.
62. Wood GM, McCormack JG, Muir DB et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027-33.
63. de Batlle J, Motje M, Balanza R, Guardia R, Ortiz R. Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia. J Clin Microbiol 2000; 38: 1694-5.
64. Westerman DA, Speed BR, Prince HM. Fatal disseminated infection by Scedosporium prolificans during induction therapy for acute leukemia: a case report and literature review. Pathology 1999; 31: 393-4.
65. Idigoras P, Perez-Trallero E, Pineiro L et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases 1990-99. Clin Infect Dis 2001; 32: E158-65.
66. Lopez L, Gaztelurrutia L, Cuenca-Estrella M et al. [Infection and colonization by Scedosporium prolificans]. Enferm Infecc Microbiol Clin 2001; 19: 308-13.
67. Tamm M, Malouf M, Glanville A. Pulmonary scedosporium infection following lung transplantation. Transpl Infect Dis 2001; 3: 189-94.
68. Simarro E, Marin F, Morales A, Sanz E, Perez J, Ruiz J. Fungemia due to Scedosporium prolificans: a description of two cases with fatal outcome. Clin Microbiol Infect 2001; 7: 645-7.
69. Guerrero A, Torres P, Duran MT, Ruiz-Diez B, Rosales M, Rodriguez-Tudela JL. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet 2001; 357 (9264): 1267-8.
70. Alvarez M, Lopez Ponga B, Rayon C et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33: 3290-5.
71. Idigoras P, Garcia-Arenzana JM, Saenz JR, Pineiro L, Marin J. [Isolation of Scedosporium prolificans from the air in the room of a patient with leukemia and disseminated infection with this fungus]. Enferm Infece Microbiol Clin 2000; 18: 426-7.
72. San Millan R, Quindos G, Garaizar J, Salesa R, Guarro J, Ponton J. Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis. J Clin Microbiol 1997; 35: 2270-4.
73. Ruiz-Diez B, Martin-Diez F, Rodriguez-Tudela JL, Alvarez M, Martinez-Suarez JV. Use of random amplification of polymorphic DNA (RAPD) and PCR-fingerprinting for genotyping a Scedosporium prolificans (inflatum) outbreak in four leukemic patients. Curr Microbiol 1997; 35: 186-90.
74. Arthur S, Steed LL, Apple DJ, Peng Q, Howard G, Escobar-Gomez M. Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. J Clin Microbiol 2001; 39: 4579-82.
75. Greig JR, Khan MA, Hopkinson NS, Marshall BG, Wilson PO, Rahman SU. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual. J Infect 2001; 43: 15-17.
76. Carreter de Granda ME, Richard C, Conde E et al. Endocarditis caused by Scedosporium prolificans after autologous peripheral blood stem cell transplantation. Eur J Clin Microbiol Infect Dis 2001; 20: 215-17.
77. Gil-Lamaignere C, Roilides E, Mosquera J, Maloukou A, Walsh TJ. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrob Agents Chemother 2002; 46: 2234-7.
78. Ortoneda M, Capilla J, Pujol I et al. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J Antimicrob Chemother 2002; 49: 525-9.
79. Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003; 47: 106-17.
80. Afeltra J, Dannaoui E, Meis JF, Rodriguez-Tudela JL, Verweij PE. In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans. Antimicrob Agents Chemother 2002; 46: 3323-6.
81. Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002; 46: 62-8.
82. Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 2002; 81: 333-48.
83. Talbot TR, Hatcher J, Davis SF, Pierson RN 3rd, Barton R, Dummer S. Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation 2002; 74: 1645-7.
84. Raj R, Frost AE. Scedosporium apiospermum fungemia in a lung transplant recipient. Chest 2002; 121: 1714-16.
85. Montejo M, Muniz ML, Zarraga S et al. Case Reports. Infection due to Scedosporium apiospermum in renal transplant recipients: a report of two cases and literature review of central nervous system and cutaneous infections by Pseudallescheria boydii/Sc. apiospermum. Mycoses 2002; 45: 418-27.
86. Miele PS, Levy CS, Smith MA et al. Primary cutaneous fungal infections in solid organ transplantation: a case series. Am J Transplant 2002; 2: 678-83.
87. Campagnaro EL, Woodside KJ, Early MG et al. Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient. Transpl Infect Dis 2002; 4: 207-11.
88. Hofman P, Saint-Paul MC, Gari-Toussaint M et al. [Disseminated infection due to Scedosporium apiospermum in liver transplantation. Differential diagnosis from invasive aspergillosis]. Ann Pathol 1993; 13: 332-5.
89. Tapia M, Richard C, Baro J et al. Scedosporium inflatum infection in immunocompromised haematological patients. Br J Haematol 1994; 87: 212-4.
90. Safdar A, Papadopoulos EB, Young JW. Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Recent Adv Antifungal Ther Transpl Infect Dis 2002; 4: 212-17.
91. Muñoz P, Marin M, Tornero P, Martin Rabadan P, Rodriguez-Creixems M, Bouza E. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 2000; 31: 1499-501.
92. Yao M, Messner AH. Fungal malignant otitis externa due to Scedosporium apiospermum. Ann Otol Rhinol Laryngol 2001; 110: 377-80.
93. Rollot F, Blanche P, Richaud-Thiriez B et al. Pneumonia due to Scedosporium apiospermum in a patient with HIV infection. Scand J Infect Dis 2000; 32: 439.
94. Eckburg PB, Zolopa AR, Montoya JG. Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS. Clin Infect Dis 1999; 29: 212-13.
95. Ichikawa T, Saiki M, Tokunaga S, Saida T. Scedosporium apiospermum skin infection in a patient with nephrotic syndrome. Acta Derm Venereol 1997; 77. 172-3.
96. Gompels MM, Bethune CA, Jackson G, Spickett GP. Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant. J Clin Pathol 2002; 55: 784-6.
97. Jabado N, Casanova JL, Haddad E et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998; 27: 1437-41.
98. Ruchel R, Wilichowski E. Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 1995; 38: 473-5.
99. Williamson EC, Speers D, Arthur IH, Harnett G, Ryan G, Inglis TJ. Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease. J Clin Microbiol 2001; 39: 47-50.
100. Wu Z, Ying H, Yiu S, Irvine J, Smith R. Fungal keratitis caused by Scedosporium apiospermum. Report of two cases and review of treatment. Cornea 2002; 21: 519-23.
101. Diaz-Valle D, Benitez del Castillo JM, Amor E, Toledano N, Carretero MM, Diaz-Valle T. Severe keratomycosis secondary to Scedosporium apiospermum. Cornea 2002; 21: 516-18.
102. Sridhar MS, Garg P, Bansal AK, Sharma S. Fungal keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2000; 26: 613-15.
103. D'Hondt K, Parys-Van Ginderdeuren R, Foets B. Fungal keratitis caused by Pseudallescheria boydii (Scedosporium apiospermum). Bull Soc Belge Ophtalmol 2000; 277: 53-6.
104. Kiratli H, Uzun O, Kiraz N, Eldem B. Scedosporium apiospermum chorioretinitis. Acta Ophthalmol Scand 2001; 79: 540-2.
105. Levine NB, Kurokawa R, Fichtenbaum CJ, Howington JA, Kuntz CT. An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis. J Spinal Disord Tech 2002; 15: 425-30.
106. Farina C, Arosio M, Marchesi G, Amer M. Scedosporium apiospermum post-traumatic cranial infection. Brain Inj 2002; 16: 627-31.
107. Canet JJ, Pagerols X, Sanchez C, Vives P, Garau J. Lymphocutaneous syndrome due to Scedosporium apiospermum. Clin Microbiol Infect 2001; 7: 648-50.
108. Kiraz N, Gulbas Z, Akgun Y, Uzun O. Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient. Clin Infect Dis 2001; 32: E59-61.
109. Tirado-Miranda R, Solera-Santos J, Brasero JC, Haro-Estarriol M, Cascales-Sanchez P, Igualada JB. Septic arthritis due to Scedosporium apiospermum. Case report and review. J Infect 2001; 43: 210-12.
110. Horre R, Feil E, Stangel AP et al. [Scedosporiosis of the brain with fatal outcome after traumatizatio of the foot. case report]. Mycoses 2000; 43 (Suppl. 2): 33-6.
111. Defontaine A, Zouhair R, Cimon B et al. Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis. J Clin Microbiol 2002; 40: 2108-14.
112. Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53-6.
113. Pistono PG, Rapetti I, Stacchini E, Guasco C. [Clinical case of mycetoma caused by Scedosporium apiospermum]. G Batteriol Virol Immunol 1989; 82: 88-91.
114. Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 2002; 34: 1648-50.
115. Nesky MA, McDougal EC, Peacock JE Jr. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis, 2000; 31: 673-7.
116. O'Bryan TA, Browne FA, Schonder JF. Scedosporium apiospermum (Pseudallescheria boydii) endocarditis. J Infect 2002; 44: 189-92.
117. Hagari Y, Ishioka S, Ohyama F, Mihara M. Cutaneous infection showing sporotrichoid spread caused by Pseudallescheria boydii (Scedosporium apiospermum) successful detection of fungal DNA in formalin-fixed, paraffin-embedded sections by seminested PCR. Arch Dermatol 2002; 138: 271-2.
118. Lavigne C, Maillot F, de Muret A, Therizol-Ferly M, Lamisse F, Machet L. Cutaneous infection with Scedosporium apiospermum in a patient treated with corticosteroids. Acta Derm Venereol 1999; 79: 402-3.
119. Bower CP, Oxley JD, Campbell CK, Archer CB. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient. J Clin Pathol 1999; 52: 846-8.
120. Torok L, Simon G, Csornai A, Tapai M, Torok I. Scedosporium apiospermum infection imitating lymphocutaneous sporotrichosis in a patient with myeloblastic-monocytic leukaemia. Br J Dermatol 1995; 133: 805-9.
121. Watson JC, Myseros JS, Bullock MR. True fungal mycotic aneurysm of the basilar artery: a clinical and surgical dilemma. Cerebrovasc Dis 1999; 9: 50-3.
122. Severo LC, Oliveira F, Garcia CD, Uhlmann A, Londero AT. Peritonitis by Scedosporium apiospermum in a patient undergoing continuous ambulatory peritoneal dialysis. Rev Inst Med Trop Sao Paulo 1999; 41: 263-4.
123. Ellis D. Amphotericin B. spectrum and resistance. J Antimicrob Chemother 2002; 49 (Suppl. 1): 7-10.
124. Liu YF, Zhao XD, Ma CL, Li CX, Zhang TS, Liao WJ. Cutaneous infection by Scedosporium apiospermum and its successful treatment with itraconazole. Clin Exp Dermatol, 1997; 22: 198-200.
125. Nomdedeu J, Brunet S, Martino R, Altes A, Ausina V, Domingo-Albos A. Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report. Clin Infect Dis, 1993; 16: 731-3.
126. Piper JP, Golden J, Brown D, Broestler J. Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole. Pediatr Infect Dis J 1990; 9: 674-5.
127. Lemerle E, Bastien M, Demolliens-Dreux G et al. [Cutaneous Scedosporium infection revealed by bullous-necrotic purpura]. Ann Dermatol Venereol 1998; 125: 711-14.
128. Hoffman HL, Rathbun RC. Review of the safety and efficacy of voriconazole. Expert Opin Invest Drugs 2002; 11: 409-29.
129. Shah KB, Wu TG, Wilhelmus KR, Jones DB. Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea 2003; 22: 33-6.
130. Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol 1998; 36: 1436-8.
131. Liu Y, Ryan ME, Lee HM et al. A chemically modified tetracycline (CMT-3) is a new antifungal agent. Antimicrob Agents Chemother 2002; 46: 1447-54.